Research Article
Serum Level of D-Lactate in Patients with Cystic Fibrosis: Preliminary Data
Table 2
Serum levels of D-lactate in relation to clinical symptoms of cystic fibrosis (median: 1–3 quartiles).
| | Serum D-lactate (μg/ml) | Statistical significance |
| CFTR mutation | | | | delF508del/delF508del | | 0.95 (0.67–1.03) | | delF508del/other | | 0.76 (0.64–0.93) | | Other | | 0.69 (0.60–0.78) | |
| Pancreatic insufficiency | Yes
| 1.05 (0.74–1.20) | | No
| 0.73 (0.63–0.87) | |
| Malnutrition | Yes
| 0.85 (0.64–1.06) | | No
| 0.77 (0.71–0.88) | |
| Liver dysfunction | Yes
| 0.70 (0.65–0.97) | | No
| 0.76 (0.65–0.95) | |
| Symptoms from respiratory tract/recurrent respiratory tract infection | Yes
| 0.77 (0.67–1.02) | | No
| 0.75 (0.63–0.94) | |
| Salt-loss syndrome | Yes
| 0.95 (0.72–1.22) | | No
| 0.73 (0.64–0.94) | |
|
|